Global Medical REIT, Inc engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.
Industry, Sector and Symbol
Industry Real estate investment trusts
Sub-IndustryN/A
SectorFinance
CIKN/A
Phone202-524-6851
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$53.19 million
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date11/4/2019 (Estimated)
OptionableOptionable
Global Medical REIT (NYSE:GMRE) Frequently Asked Questions
What is Global Medical REIT's stock symbol?
Global Medical REIT trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMRE."
How often does Global Medical REIT pay dividends? What is the dividend yield for Global Medical REIT?
Global Medical REIT declared a quarterly dividend on Monday, June 17th. Stockholders of record on Wednesday, June 26th will be given a dividend of $0.20 per share on Thursday, July 11th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 7.36%. The ex-dividend date is Tuesday, June 25th. View Global Medical REIT's Dividend History.
How were Global Medical REIT's earnings last quarter?
Global Medical REIT Inc (NYSE:GMRE) issued its earnings results on Wednesday, August, 7th. The company reported $0.03 EPS for the quarter, missing analysts' consensus estimates of $0.19 by $0.16. The business had revenue of $16.88 million for the quarter, compared to analysts' expectations of $16.74 million. Global Medical REIT had a net margin of 24.11% and a return on equity of 5.91%. View Global Medical REIT's Earnings History.
When is Global Medical REIT's next earnings date?
What price target have analysts set for GMRE?
5 analysts have issued twelve-month price objectives for Global Medical REIT's stock. Their forecasts range from $9.03 to $11.00. On average, they anticipate Global Medical REIT's stock price to reach $10.6060 in the next twelve months. This suggests that the stock has a possible downside of 2.5%. View Analyst Price Targets for Global Medical REIT.
What is the consensus analysts' recommendation for Global Medical REIT?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Global Medical REIT in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Global Medical REIT.
What are Wall Street analysts saying about Global Medical REIT stock?
Here are some recent quotes from research analysts about Global Medical REIT stock:
- 1. According to Zacks Investment Research, "Global Medical REIT Inc. is engaged primarily in the acquisition of licensed, state-of-the-art, purpose-built healthcare facilities and the leasing of these facilities to clinical operators. Global Medical REIT Inc. is based in Denver, United States. " (7/11/2019)
- 2. Boenning Scattergood analysts commented, "We think that GMRE could have purchasing power remaining, on the order of $25 million to $35 million, and that incremental acquisition activity in 2019 will be funded by the newly expanded credit facility and ATM offerings. While GMRE’s portfolio acquisition offered an attractive ROI, we think that future acquisitions will be one-off properties — probably medical office – priced around its sweet spot of $10 million on average. Based on what we know about the timing of acquisitions in April and what we estimate in terms of acquisition activity over the balance of the year, we are raising our forward NAV estimate from $10.30 to $10.50." (5/10/2019)
Has Global Medical REIT been receiving favorable news coverage?
News headlines about GMRE stock have been trending positive this week, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Global Medical REIT earned a daily sentiment score of 2.5 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 6.0 out of 10, meaning that recent press coverage is somewhat likely to have an impact on the company's share price in the next several days. View News Stories for Global Medical REIT.
Are investors shorting Global Medical REIT?
Global Medical REIT saw a decrease in short interest in July. As of July 31st, there was short interest totalling 389,500 shares, a decrease of 18.3% from the June 30th total of 476,600 shares. Based on an average daily trading volume, of 282,600 shares, the short-interest ratio is currently 1.4 days. Currently, 2.6% of the company's stock are short sold. View Global Medical REIT's Current Options Chain.
Who are some of Global Medical REIT's key competitors?
Some companies that are related to Global Medical REIT include NY MTG TR INC/SH (NYMT), Brookfield Property Reit (BPR), TPG RE Finance Trust (TRTX), Industrial Logistics Properties Trust (ILPT), Tanger Factory Outlet Centers (SKT), Interrent Real Estate Investment Trust (IIPZF), Universal Health Realty Income Trust (UHT), American Finance Trust (AFIN), Monmouth R.E. Inv. (MNR), Kite Realty Group Trust (KRG), Independence Realty Trust (IRT), Saul Centers (BFS), Summit Hotel Properties (INN), ARBOR RLTY TR I/SH (ABR) and KKR Real Estate Finance Trust (KREF).
What other stocks do shareholders of Global Medical REIT own?
Who are Global Medical REIT's key executives?
Global Medical REIT's management team includes the folowing people:
- Jeffrey Mark Busch, Chairman, President & Chief Executive Officer
- Danica Holley, Chief Operating Officer
- Robert J. Kiernan, Chief Financial Officer & Treasurer
- Alfonzo Leon, Chief Investment Officer
- Allen E. Webb, Senior VP-SEC Reporting & Technical Accounting
When did Global Medical REIT IPO?
(GMRE) raised $130 million in an initial public offering on Wednesday, June 29th 2016. The company issued 13,000,000 shares at a price of $10.00 per share. Wunderlich and Oppenheimer acted as the underwriters for the IPO and BB&T Capital Markets, Compass Point and D.A. Davidson were co-managers.
Who are Global Medical REIT's major shareholders?
Global Medical REIT's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (6.63%), Vanguard Group Inc. (5.88%), State of New Jersey Common Pension Fund D (2.03%), Wells Fargo & Company MN (1.80%), Psagot Investment House Ltd. (1.67%) and Marshall Wace LLP (1.49%). Company insiders that own Global Medical REIT stock include Henry Cole, Jeffrey Busch, Matthew Cypher, Ronald Marston, Roscoe M Moore Jr and Zh Usa, Llc. View Institutional Ownership Trends for Global Medical REIT.
Which major investors are selling Global Medical REIT stock?
GMRE stock was sold by a variety of institutional investors in the last quarter, including Man Group plc, Marshall Wace LLP, BB&T Securities LLC, Renaissance Technologies LLC, Morgan Stanley, Invesco Ltd., Psagot Investment House Ltd. and ClariVest Asset Management LLC. View Insider Buying and Selling for Global Medical REIT.
Which major investors are buying Global Medical REIT stock?
GMRE stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Wells Fargo & Company MN, Nuveen Asset Management LLC, Vanguard Group Inc., United Services Automobile Association, Charles Schwab Investment Management Inc., Victory Capital Management Inc. and National Investment Services Inc. WI. Company insiders that have bought Global Medical REIT stock in the last two years include Henry Cole, Jeffrey Busch, Matthew Cypher, Ronald Marston and Zh Usa, Llc. View Insider Buying and Selling for Global Medical REIT.
How do I buy shares of Global Medical REIT?
Shares of GMRE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Global Medical REIT's stock price today?
One share of GMRE stock can currently be purchased for approximately $10.8750.
How big of a company is Global Medical REIT?
Global Medical REIT has a market capitalization of $384.98 million and generates $53.19 million in revenue each year. The company earns $13.49 million in net income (profit) each year or $0.78 on an earnings per share basis. View Additional Information About Global Medical REIT.
What is Global Medical REIT's official website?
How can I contact Global Medical REIT?
Global Medical REIT's mailing address is 2 Bethesda Metro Center Suite 440, BETHESDA MD, 20814. The company can be reached via phone at 202-524-6851.
MarketBeat Community Rating for Global Medical REIT (NYSE GMRE)
MarketBeat's community ratings are surveys of what our community members think about Global Medical REIT and other stocks. Vote "Outperform" if you believe GMRE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GMRE will underperform the S&P 500 over the long term. You may vote once every thirty days.
